Search This Blog

Thursday, January 9, 2020

Amarin says no change to Vascepa status at UnitedHealth

Amarin (NASDAQ:AMRN) investor relations says there’s no indication of a change to UnitedHealthcare’s 2020 coverages of Vascepa vs. 2019.
A story yesterday based on this document said the drug had been moved to “non-preferred” status.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)